February 18, 2021 -- Immunome has isolated potent antibodies that are capable of neutralizing several SARS-CoV-2 variants, including the South African variant (B.1.351), in pseudovirus testing.
The company discovered these antibodies by analyzing serum from SARS-CoV-2 "super-responders" who recovered from COVID-19 and mounted a robust immune response to a broad range of viral targets.
In July 2020, the company was awarded a $13.3 million technology award from the U.S. Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) in collaboration with the Defense Health Agency.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
